What proof proves about calcitonin and clinical trials
- 1 September 2000
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 109 (4), 330-331
- https://doi.org/10.1016/s0002-9343(00)00539-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures studyAmerican Journal Of Medicine, 2000
- CalcitoninPublished by Elsevier BV ,1998
- Salmon calcitonin in the prevention of bone loss at perimenopauseBone, 1996
- Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosisBone, 1996
- Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndromeBone and Mineral, 1992
- CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSSThe Lancet, 1988
- 1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONINThe Lancet, 1987
- Axial and Appendicular Bone Mineral Density in Patients with Long-Term Deficiency or Excess of CalcitoninNew England Journal of Medicine, 1987
- Calcitonin Secretion in Postmenopausal OsteoporosisNew England Journal of Medicine, 1985
- Basal plasma immunoreactive calcitonin in postmenopausal osteoporosisMetabolism, 1980